Kenneth Maswabi

Gaborone, Botswana

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Immune correlates of HIV-1 rebound during broadly neutralizing antibody treatment in young children.

Immune correlates of HIV-1 rebound during broadly neutralizing antibody treatment in young children.

Journal: The Journal of clinical investigation

Published: June 27, 2025

Predictive markers for sustained viral suppression on dual bNAbs during ART interruption in children.

Predictive markers for sustained viral suppression on dual bNAbs during ART interruption in children.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: March 26, 2025

Correction: Caregivers of children with HIV in Botswana prefer monthly IV Broadly Neutralizing Antibodies (bNAbs) to daily oral ART.

Correction: Caregivers of children with HIV in Botswana prefer monthly IV Broadly Neutralizing Antibodies (bNAbs) to daily oral ART.

Journal: PloS one

Published: July 10, 2024

Caregivers of children with HIV in Botswana prefer monthly IV Broadly Neutralizing Antibodies (bNAbs) to daily oral ART.

Caregivers of children with HIV in Botswana prefer monthly IV Broadly Neutralizing Antibodies (bNAbs) to daily oral ART.

Journal: PloS one

Published: November 15, 2023

Broadly neutralizing antibody treatment maintained HIV suppression in children with favorable reservoir characteristics in Botswana.

Broadly neutralizing antibody treatment maintained HIV suppression in children with favorable reservoir characteristics in Botswana.

Journal: Science translational medicine

Published: July 05, 2023

Immune Modulation of HIV-1 Reservoir Size in Early-Treated Neonates.

Immune Modulation of HIV-1 Reservoir Size in Early-Treated Neonates.

Journal: The Journal of infectious diseases

Published: March 27, 2023

Brief Report: Long-Term Clinical, Immunologic, and Virologic Outcomes Among Early-Treated Children With HIV in Botswana: A Nonrandomized Controlled Clinical Trial.

Brief Report: Long-Term Clinical, Immunologic, and Virologic Outcomes Among Early-Treated Children With HIV in Botswana: A Nonrandomized Controlled Clinical Trial.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: August 18, 2022

Safety and Pharmacokinetics of Intravenous 10-1074 and VRC01LS in Young Children.

Safety and Pharmacokinetics of Intravenous 10-1074 and VRC01LS in Young Children.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: January 10, 2022

Immune correlates of HIV-1 reservoir cell decline in early-treated infants.

Immune correlates of HIV-1 reservoir cell decline in early-treated infants.

Journal: Cell reports

Published: December 13, 2021

Patterns of pretreatment drug resistance mutations of very early diagnosed and treated infants in Botswana.

Patterns of pretreatment drug resistance mutations of very early diagnosed and treated infants in Botswana.

Journal: AIDS (London, England)

Published: July 29, 2021

Viral Reservoir in Early-Treated Human Immunodeficiency Virus-Infected Children and Markers for Sustained Viral Suppression.

Viral Reservoir in Early-Treated Human Immunodeficiency Virus-Infected Children and Markers for Sustained Viral Suppression.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: September 03, 2020

HIV diagnostic algorithm requires confirmatory testing for initial indeterminate or positive screens in the first week of life.

HIV diagnostic algorithm requires confirmatory testing for initial indeterminate or positive screens in the first week of life.

Journal: AIDS (London, England)

Published: April 15, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026